Comparison of the Effects of Deferiprone versus Deferoxamine on Growth and Virulence of Yersinia enterocolitica

Deferoxamine, a drug used to treat patients with iron overload, has the capacity to promote systemic Y. enterocolitica infections in humans. The aim of this study was to determine whether deferiprone, the only orally active alternative treatment, has the same potential. When Y. enterocolitica IP864...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Lesic, Biliana, Foulon, Jeannine, Carniel, Elisabeth
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2002
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127255/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019084/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.1741-1745.2002
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!